Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …

Objective To provide guidance to rheumatology providers on the use of coronavirus disease
2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases …

Secondary hypogammaglobulinemia (SHG) is characterized by reduced immunoglobulin
levels due to acquired causes of decreased antibody production or increased antibody loss …

Objective To update guidance regarding the management of psoriatic disease during the
COVID-19 pandemic. Study Design The task force (TF) includes 18 physician voting …

Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …

Aim To present a systematic literature review (SLR) on efficacy, immunogenicity and safety
of vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

In this study, we report the safety of coronavirus disease 2019 (COVID-19) vaccine in
patients with myasthenia gravis (MG). Patients who were vaccinated against COVID-19 were …

Vaccines are important for protecting individuals at increased risk of severe infections,
including patients undergoing DMARD therapy. However, DMARD therapy can also …

Almost 1 year into the coronavirus disease 2019 (COVID-19) pandemic, and after more than
50 million cases and 1.35 million deaths globally, reports of the successful conclusion of …